Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Prevention of Capecitabine-Induced Hand-Foot Syndrome
NCT00305643Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of celecoxib oral solution in palmar-plantar erythrodysesthesia (PPE), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2006; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
palmar-plantar erythrodysesthesia (PPE)
Beyond the preview
Go deeper on NCT00305643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305643.